Sunshine Biopharma (SBFM) EPS (Basic) (2017 - 2026)

Sunshine Biopharma (SBFM) posted EPS (Basic) of -$2.54 for Q1 2026, up 50.77% on a QoQ basis from -$5.15 in Q4 2025, and up 41.9% year-over-year from -$1.79 in Q1 2025.

Sunshine Biopharma (SBFM) EPS (Basic) (2017 - 2026) Analysis & Trends

Sunshine Biopharma's EPS (Basic) history runs 9 years deep, the most recent figure standing at -$2.54 for Q1 2026.

  • Quarterly EPS (Basic) rose 41.9% year-over-year to -$2.54 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.31 (up 47.29% YoY) and the FY2025 annual result came in at -$14.37, up 80.35% from the prior year.
  • EPS (Basic) was -$2.54 for Q1 2026 at Sunshine Biopharma, up from -$5.15 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.65 in Q3 2025 and bottomed at -$30978.0 in Q4 2022.
  • A 5-year average of -$2497.6 and a median of -$400.31 in 2024 frame the typical range for EPS (Basic).
  • Annual changes were most pronounced in 2022 — EPS (Basic) plunged 708.31% — and 2025, when it soared 106.87%.
  • Sunshine Biopharma's EPS (Basic) stood at -$30978.0 in 2022, then jumped by 96.79% to -$995.87 in 2023, then soared by 96.91% to -$30.75 in 2024, then jumped by 83.25% to -$5.15 in 2025, then surged by 50.77% to -$2.54 in 2026.
  • Business Quant data shows SBFM's EPS (Basic) at -$2.54 in Q1 2026, -$5.15 in Q4 2025, and $0.65 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 0.32
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 1.42
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -1.49
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 6.32
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 0.15
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 1.97
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 0.11
10 Sunshine Biopharma 750,608.81 -6.16 Mn 2.18 Mn -2.54

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.54
Dec 31, 2025 -5.15
Sep 30, 2025 0.65
Jun 30, 2025 -6.56
Mar 31, 2025 -4.36
Dec 31, 2024 -30.75
Sep 30, 2024 -9.45
Jun 30, 2024 -357.55
Mar 31, 2024 -400.31
Dec 31, 2023 -995.87
Sep 30, 2023 -506.99
Jun 30, 2023 -711.44
Mar 31, 2023 -1,544.85
Dec 31, 2022 -30,978.02
Sep 30, 2022 -1,543.45
Jun 30, 2022 -680.39
Mar 31, 2022 -4,682.70
Dec 31, 2021 5,092.49
Sep 30, 2021 -31,806.17
Jun 30, 2021 -23,992.12